Sun Pharma and Taro Terminate Proposed Merger

Taro Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries Ltd. have agreed to terminate their merger agreement, announced in August 2012, whereby all shareholders of Taro (other than Sun Pharma and its affiliates) would have received a cash payment of $39.50 per share upon the closing of the merger. Both companies agreed that terminating the merger agreement was in the best interest of the respective companies and shareholders. Read more

More News:

All news »

What are your comments?

Join the discussion today. Login Here.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments